Skip to main content
Figure 1 | Malaria Journal

Figure 1

From: Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

Figure 1

patient flow chart. Enrollment, randomization and follow-up of the patients. § The reasons for exclusion (number of patients) were ear discharge (20), impacted ear wax (18), repeated previous otitis media (14), perforated ear drum (6), negative TEOAE recording (15), Weber test lateralized (10), self-treatment with chloroquine (18), mixed infection (17), pregnancy (15). * Patients treated with a second course of antimalarials because of recrudescence or new infection were excluded from audiovestibular evaluation.

Back to article page